Was published
Advertising
The main test began to consider whether a simple blood test can replace invasive and expensive procedures in diagnosis Alzheimer’s disease – A disease that affects millions of people around the world.
Leading researchers at the University College of London in the UK, the test began to consume patients through clinics throughout the country.
He will try whether the blood protein levels in blood protein can provide a timely and reliable diagnosis of Alzheimer’s disease, helping patients and doctors take faster and more informed care decisions.
Currently, confirmation of the diagnosis of Alzheimer’s disease is usually based on scanning of the brain or lumbar punctures, which are expensive and inaccessible to access.
And according to The study of Alzheimer Great BritainOnly 2% of people with the diagnosis of the disease are currently undergoing one of these “gold” tests.
“Revolution in the method of diagnosing dementia”
“After decades of research, we now have a blood test for Alzheimer’s disease, supported by powerful scientific elements, and provide comparable information with other diagnostic research of gold standards, such as scanning RET and lumbar thirst, but much more accessible and cheaper,” from the test.
The test will include 1,100 participants in 20 NHS centers. Half will receive the results of blood tests within three months, and the other half will receive them in a year. Then the researchers measure whether the diagnosis accelerates early access to the results, changes clinical solutions or affects the quality of life of patients.
For many families, the prospect of a faster path to diagnosis gives hope. Michael White, who takes care of his wife Katherine, said that their path to the diagnosis lasted two and a half years. “A similar blood test will help to make a diagnosis from the very beginning and will have a real meaning for us,” he said.
The study is part of the Biomarker Biomarker contest, a multifunctional program supported by the Alzheimer society, research in the field of Alzheimer in the UK and folk players in the lottery of postal indices.
If the test is successful, it can pave the path to blood test to become a key part of dementia care in NHS.
In accordance with Alzheimer disease InternationalThere are more than 10 million new cases of dementia per year, corresponding to a new case every 3.2 seconds.
And in 2020, more than 55 million people lived with dementia around the world, which is expected to double every 20 years, reaching 78 million by 2030 and 139 million by 2050.